|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Profit & Loss |
|
| Laurus Labs Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: | 540222 | | NSE Symbol: | LAURUSLABS | | P/E : | 108.49 | ISIN Demat: | INE947Q01028 | | Div & Yield %: | 0.09 | | EPS : | 4.15 | Book Value: | 78.057879 | | Market Cap (Rs.Cr): | 24266.94 | | Face Value : | 2 | |
|
(Rs. In Crores) |
|
| | | | | | Sales Turnover | 5773.45 | 4707.04 | 4768.72 | 2797.34 | 2236.15 | 2039.29 | Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.45 | Net Sales | 5773.45 | 4707.04 | 4768.72 | 2797.34 | 2236.15 | 2026.84 | Other Income | 15.95 | 21.55 | 27.32 | 5.81 | 16.13 | 28.84 | Stock Adjustments | -40.82 | 218.62 | 296.45 | 218.09 | 28.92 | 25.11 | Total Income | 5748.58 | 4947.21 | 5092.49 | 3021.24 | 2281.20 | 2080.79 | | | | | | | Raw Materials | 2671.65 | 2427.18 | 2471.58 | 1620.64 | 1237.85 | 1081.51 | Power & Fuel Cost | 301.10 | 188.52 | 149.69 | 132.62 | 105.50 | 90.54 | Employee Cost | 477.88 | 417.57 | 364.83 | 299.90 | 256.85 | 218.24 | Other Manufacturing Expenses | 431.99 | 326.34 | 298.12 | 191.38 | 151.49 | 128.72 | Selling & Administrative Expenses | 323.95 | 265.52 | 260.60 | 190.04 | 145.00 | 117.75 | Miscellaneous Expenses | 44.30 | 15.33 | 10.48 | 10.62 | 16.92 | 6.44 | Less : Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Expenditure | 4250.87 | 3640.46 | 3555.30 | 2445.20 | 1913.61 | 1643.20 | Operating Profit | 1497.71 | 1306.75 | 1537.19 | 576.04 | 367.58 | 437.58 | Interest | 145.70 | 95.86 | 65.92 | 87.71 | 85.83 | 75.44 | Gross Profit | 1352.01 | 1210.89 | 1471.27 | 488.33 | 281.75 | 362.14 | Depreciation | 300.58 | 235.48 | 196.64 | 183.85 | 160.53 | 121.23 | Profit Before Tax | 1051.43 | 975.41 | 1274.63 | 304.48 | 121.22 | 240.91 | Tax | 270.78 | 231.42 | 334.98 | 53.00 | 24.83 | 52.97 | Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | 20.27 | -6.10 | -16.46 | -15.57 | 1.39 | 14.80 | Reported Net Profit | 760.38 | 750.09 | 956.11 | 267.05 | 94.99 | 173.14 | Extraordinary Items | -0.14 | -0.85 | -0.63 | -0.67 | -0.62 | -0.37 | Adjusted Net Profit | 760.52 | 750.94 | 956.74 | 267.72 | 95.61 | 173.51 | Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | -3.50 | -3.27 | 0.00 | P & L Balance brought forward | 2577.18 | 1912.95 | 1031.88 | 803.63 | 727.81 | 573.76 | Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Appropriations | 107.47 | 85.86 | 75.04 | 35.30 | 15.90 | 19.09 | P & L Balance carried down | 3230.09 | 2577.18 | 1912.95 | 1031.88 | 803.63 | 727.81 | Dividend | 107.47 | 85.86 | 75.04 | 16.04 | 0.00 | 15.90 | Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Dividend % | 100.00 | 100.00 | 100.00 | 25.00 | 15.00 | 15.00 | Dividend Per Share(Rs) | 2.00 | 2.00 | 2.00 | 2.50 | 1.50 | 1.50 | Earnings Per Share-Unit Curr | 14.12 | 13.96 | 17.82 | 24.98 | 8.92 | 16.33 | Earnings Per Share(Adj)-Unit Curr | 14.12 | 13.96 | 17.82 | 5.00 | 1.78 | 3.27 | Book Value-Unit Curr | 75.31 | 63.05 | 50.54 | 169.84 | 149.47 | 142.72 | Book Value(Adj)-Unit Curr | 75.31 | 63.05 | 50.54 | 33.97 | 29.89 | 28.54 |
|
|
|
|
|
|